Clinical trial
A Study to Evaluate the Relative Bioavailability of Two Metronidazole Vaginal Gel Formulations
NCT01020877 is registered in ClinicalTrials.gov with Teva Pharmaceuticals USA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Relative Bioavailability of Two Metronidazole Vaginal Gel Formulations
- Lead sponsor
- Teva Pharmaceuticals USA
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2001
- Completion date
- January 31, 2002
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy